Medicare Enrolled
Dr. Richard Feibelman, M.D.
Critical Care Medicine · Palatka, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Feibelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feibelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Feibelman
Dr. Richard Feibelman is a critical care medicine specialist in Palatka, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Feibelman performed 3,456 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Feibelman received a total of $5,175 from 21 pharmaceutical and/or device companies across 214 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feibelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in FL
$5,175 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 38708 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,456
Medicare services
Top 7% in FL for critical care medicine
Not available
Unique patients (not deduplicated)
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
771 | $92 | $150 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
609 | $166 | $387 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
449 | $92 | $131 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
291 | $128 | $225 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
157 | $62 | $104 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
147 | $120 | $250 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
141 | $39 | $105 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
139 | $39 | $108 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
134 | $25 | $48 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
133 | $28 | $100 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
116 | $12 | $36 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
90 | $77 | $220 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $62 | $110 |
| Spirometry test A test that measures the amount of air you can exhale and how fast you can blow it out. The provider evaluates the results to check lung function. |
49 | $18 | $27 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $102 | $300 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
43 | $86 | $243 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
16 | $138 | $413 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
15 | $114 | $217 |
| Chest fluid drainage with tube insertion using imaging guidance This procedure removes fluid from the chest cavity and places a tube to stay in place for ongoing drainage. Imaging guidance is used to help position the tube accurately. |
15 | $114 | $523 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
14 | $105 | $289 |
| New patient office visit, complex (60-74 min) | 12 | $155 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,175
Total received (2018-2024)
Avg $739/year across 7 years
Top 25% in FL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
214
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,534
2023
$1,059
2022
$902
2021
$448
2020
$586
2019
$434
2018
$213
Payments by company (2024)
Medtronic, Inc.
$1,011
AstraZeneca Pharmaceuticals LP
$174
GlaxoSmithKline, LLC.
$124
Amgen Inc.
$51
Philips North America LLC
$34
Inspire Medical Systems, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Mylan Specialty L.P.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Insmed, Inc.
$25
Top 3 companies account for 85.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,012
Medtronic, Inc.
$1,011
GlaxoSmithKline, LLC.
$978
Boehringer Ingelheim Pharmaceuticals, Inc.
$553
Amgen Inc.
$258
Baxter Healthcare
$215
Regeneron Healthcare Solutions, Inc.
$187
GENZYME CORPORATION
$164
Sunovion Pharmaceuticals Inc.
$138
Takeda Pharmaceuticals U.S.A., Inc.
$110
Mylan Specialty L.P.
$109
Insmed, Inc.
$87
Genentech USA, Inc.
$76
Pulmonx Corporation
$63
Philips Electronics North America Corporation
$46
Inspire Medical Systems, Inc.
$46
Allergan Inc.
$38
Philips North America LLC
$34
Vapotherm Inc
$22
Inogen, Inc.
$18
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 58.0% of all-time payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) inCourage · AIRSUPRA · ANORO · AVYCAZ · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · DUPIXENT · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · ILLUMISITE · IMFINZI · INOGEN · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · SIGNIA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TANZEUM · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · Utibron · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
4
County median income
$47,256
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA PUTNAM HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Feibelman is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Feibelman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Feibelman performed 771 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Feibelman receive payments from pharmaceutical companies?
Yes. Dr. Feibelman received a total of $5,175 from 21 companies across 214 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feibelman's costs compare to other critical care medicines in Palatka?
Dr. Feibelman's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feibelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Palatka
Browse critical care medicines in Palatka ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology